SUNNYVALE, Calif., March 05, 2020 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today that effective as of market open on March 6, 2020, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol "SILK".
Read More: https://www.globenewswire.com/news-release/2020/03/06/1996268/0/en/Silk-Road-Medical-Announces-Uplisting-to-the-Nasdaq-Global-Select-Market.html#:~:text=(Nasdaq%3A%20SILK)%20(%E2%80%9C,trading%20under%20its%20current%20ticker